News
The FDA has approved medications like Zepbound and Wegovy for weight loss, which use the same active ingredient as the ...
Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...
David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...
2h
Oprah Daily on MSNDoes Combining Hormone Therapy and a GLP-1 Boost Your Menopausal Weight Loss? Here's What the Research SaysMenopausal hormone treatment (MHT) might indirectly help with weight loss by improving sleep and redistributing abdominal fat ...
Novo Nordisk (NYSE: NVO) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...
Jeffrey Casberg, M.S., vice president of clinical pharmacy at IPD Analytics, shared his insights on the results of Managed Healthcare Executive’s annual Pharmacy Survey in this part-two interview of a ...
While research suggests having a higher weight may increase your risk for certain conditions, people can be healthy at every ...
Noom will start offering smaller doses of compounded Wegovy (NVO), the blockbuster weight-loss drug, as the digital health ...
On a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t expect was to also lose their taste for alcohol. A new study has found that ...
Respondents see the glucagon-like peptide 1 (GLP-1) drugs as a major advance. They also have concerns about whether insurers ...
SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, ...
Glucagon-like peptide-1 receptor agonists are tied to a reduction in alcohol intake in patients being treated for obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results